Trials / Sponsors / Rare Thyroid Therapeutics International AB
Rare Thyroid Therapeutics International AB
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Withdrawal of Tiratricol Treatment in Males With Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency) Monocarboxylate Transporter 8 Deficiency, Allan-Herndon-Dudley Syndrome | Phase 3 | 2023-07-21 |
| Completed | MCT8 Deficiency Caregiver Study Monocarboxylate Transporter 8 (MCT8) Deficiency, Allan-Herndon-Dudley Syndrome | — | 2022-08-23 |
| Active Not Recruiting | Triac Trial II in MCT8 Deficiency Patients Allan-Herndon-Dudley Syndrome | Phase 2 | 2020-12-07 |
| Available | Expanded Access Program for Tiratricol in Patients With Monocarboxylate Transporter 8 Deficiency Monocarboxylate Transporter 8 Deficiency, Allan-Herndon-Dudley Syndrome | — | — |